Ikarian Capital, LLC Amylyx Pharmaceuticals, Inc. Transaction History
Ikarian Capital, LLC
- $606 Million
- Q4 2024
A detailed history of Ikarian Capital, LLC transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 201,187 shares of AMLX stock, worth $732,320. This represents 0.13% of its overall portfolio holdings.
Number of Shares
201,187
Previous 274,551
26.72%
Holding current value
$732,320
Previous $889,000
14.74%
% of portfolio
0.13%
Previous 0.16%
Shares
7 transactions
Others Institutions Holding AMLX
# of Institutions
142Shares Held
49.1MCall Options Held
281KPut Options Held
438K-
Perceptive Advisors LLC New York, NY6.77MShares$24.7 Million0.85% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA4.64MShares$16.9 Million2.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$9.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$9.72 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC2.43MShares$8.83 Million0.0% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $213M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...